-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Complications and management of hyperkalemia: implications for the use of the novel cation exchangers zirconium cyclosilicate and patiromer
Lama Noureddine & Bradley S Dixon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Complications and management of hyperkalemia: implications for the use of the novel cation exchangers zirconium cyclosilicate and patiromer
Lama Noureddine & Bradley S Dixon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Complications and management of hyperkalemia: implications for the use of the novel cation exchangers zirconium cyclosilicate and patiromer
Lama Noureddine & Bradley S Dixon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Complications and management of hyperkalemia: implications for the use of the novel cation exchangers zirconium cyclosilicate and patiromer
Lama Noureddine & Bradley S Dixon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Complications and management of hyperkalemia: implications for the use of the novel cation exchangers zirconium cyclosilicate and patiromer
Lama Noureddine & Bradley S Dixon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Complications and management of hyperkalemia: implications for the use of the novel cation exchangers zirconium cyclosilicate and patiromer
Lama Noureddine & Bradley S Dixon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Complications and management of hyperkalemia: implications for the use of the novel cation exchangers zirconium cyclosilicate and patiromer
Lama Noureddine & Bradley S Dixon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Complications and management of hyperkalemia: implications for the use of the novel cation exchangers zirconium cyclosilicate and patiromer
Lama Noureddine & Bradley S Dixon
Review: Clinical Trail Outcomes: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Over reporting of p-values in the medical literature should be discouraged
Eric P Brass
Editorial: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation